试图戒烟和成功戒烟期间在杜拉格卢提德治疗中体重增加的性别差异:随机试验的预定义二次分析
Fabienne Baur1,2, Cihan Atila1,2, Sophia Lengsfeld1,2
1Department of Endocrinology, Diabetology and Metabolism, University Hospital Basel, Basel, Switzerland.
BMJ nutrition, prevention & health
|January 24, 2024
概括
杜拉古类药物有效地减少了男性和女性的体重增加. 这种药物特别有效地预防女性的显著体重增加,这是戒烟期间常见的担忧.
科学领域:
- 临床试验 临床试验
- 药理学 药理学 是一个学科.
- 成 药物 药物 药物 药物
背景情况:
- 女性在戒烟方面面临的挑战比男性更大.
- 吸烟对健康构成重大风险,尤其对女性来说.
- 戒烟后体重增加是试图戒烟的女性的主要担忧.
研究的目的:
- 为了研究戒烟后体重变化中的性别差异.
- 为了评估杜拉格卢提德在管理停产后体重增加方面的有效性.
- 为了确定杜拉格卢提德是否会减轻女性吸烟者的显著体重增加.
主要方法:
- 一个随机对照试验的二次分析 (NCT03204396).
- 255名成年吸烟者 (155名女性,100名男性) 接受了杜拉格卢或安慰剂,并获得戒烟支持.
- 在12周内评估体重变化,包括显著的体重增加 (>6%的增加).
主要成果:
- 对于杜拉格卢提德或安慰剂,没有观察到绝对或相对体重变化中的性别差异.
- 在安慰剂组中,女性 (24%) 的体重增加明显高于男性 (5%).
- 与安慰剂 (24%) 相比,杜拉古类药物显著降低了女性的显著体重增加 (1%),男性的影响较小 (0%vs5%).
结论:
- 杜拉古类药物有效地降低了两性中停产后的体重增加.
- 杜拉格卢提德在防止显著体重增加方面非常有效,特别是在女性中.
- 研究结果表明,杜拉格卢提德可能会解决女性戒烟的关键障碍.
相关概念视频
01:30Bulimia Nervosa
79
Bulimia nervosa is a complex and severe eating disorder characterized by a cyclical pattern of binge-and-purge eating pattern. It generally involves an episode of binge eating, followed by compensatory behaviors such as vomiting, excessive exercise, laxative use, or fasting, to prevent weight gain. Despite often maintaining a normal weight, individuals with bulimia are intensely preoccupied with their body image and harbor an overwhelming fear of gaining weight. This can contribute to the...
79
01:24Obesity
505
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
505
01:23Binge Eating Disorders
68
Binge eating disorder is a significant mental health condition characterized by recurrent episodes of excessive food consumption within a short period, accompanied by a perceived loss of control over eating behavior. Unlike occasional overeating, binge eating disorder is marked by distressing emotions such as guilt, shame, and anxiety following binge episodes. The disorder affects individuals across different ages and backgrounds, with profound implications for physical and psychological...
68
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
120
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
120
01:22Diabetes Mellitus: Type 2 and Gestational
2.4K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.4K
01:06Oral Hypoglycemic Agents: Glinides
154
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively...
154